These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12423952)

  • 1. Three-dimensional structure of the inclusion complex between phloridzin and beta-cyclodextrin.
    Ishizuka Y; Fujiwara M; Kanazawa K; Nemoto T; Fujita K; Nakanishi H
    Carbohydr Res; 2002 Oct; 337(19):1737-43. PubMed ID: 12423952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and molecular docking investigations on the inclusion mechanism of the complex of phloridzin and hydroxypropyl-β-cyclodextrin.
    Zhang CL; Liu JC; Yang WB; Chen DL; Jiao ZG
    Food Chem; 2017 Jan; 215():124-8. PubMed ID: 27542458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation.
    Aki H; Niiya T; Iwase Y; Yamamoto M
    J Pharm Sci; 2001 Aug; 90(8):1186-97. PubMed ID: 11536223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR studies of the inclusion complex between beta-cyclodextrin and paroxetine.
    Bernini A; Spiga O; Ciutti A; Scarselli M; Bottoni G; Mascagni P; Niccolai N
    Eur J Pharm Sci; 2004 Aug; 22(5):445-50. PubMed ID: 15265514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modelling and 1H-NMR: ultimate tools for the investigation of tolbutamide: beta-cyclodextrin and tolbutamide: hydroxypropyl-beta-cyclodextrin complexes.
    Veiga FJ; Fernandes CM; Carvalho RA; Geraldes CF
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1251-6. PubMed ID: 11605649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of imazalil/beta-cyclodextrin inclusion complex.
    Consonni R; Recca T; Dettori MA; Fabbri D; Delogu G
    J Agric Food Chem; 2004 Mar; 52(6):1590-3. PubMed ID: 15030216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis and modelling of the structures of beta-cyclodextrin complexes.
    Myles AM; Barlow DJ; France G; Lawrence MJ
    Biochim Biophys Acta; 1994 Jan; 1199(1):27-36. PubMed ID: 8280750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR spectra and structures of oridonin derivatives complexes with β-cyclodextrin.
    Liu W; Zhao B; Li YC; Liu HM
    Magn Reson Chem; 2011 Sep; 49(9):611-5. PubMed ID: 21815208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inclusion complexes of ketosteroids with beta-cyclodextrin.
    Forgo P; Vincze I; Kövér KE
    Steroids; 2003 Apr; 68(4):321-7. PubMed ID: 12787893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR spectroscopic study of cyclodextrin inclusion complexes with A-007 prodrugs.
    Sagiraju S; Jursic BS
    Carbohydr Res; 2008 May; 343(7):1180-90. PubMed ID: 18384761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereochemistry and dynamics of the inclusion complex of (S)-(+)-fenoprofen with cyclomaltoheptaose (beta-cyclodextrin).
    Uccello-Barretta G; Chiavacci C; Bertucci C; Salvadori P
    Carbohydr Res; 1993 Apr; 243(1):1-10. PubMed ID: 8324756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of molecular association in drug: cyclodextrin inclusion complexes with improved 1H NMR studies.
    Loukas YL
    J Pharm Pharmacol; 1997 Oct; 49(10):944-8. PubMed ID: 9364400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between beta-cyclodextrin and 1,10-phenanthroline: uncommon 2:3 inclusion complex in the solid state.
    Liu Y; Chen GS; Zhang HY; Song HB; Ding F
    Carbohydr Res; 2004 Jun; 339(9):1649-54. PubMed ID: 15183740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrin.
    Moyano JR; Arias-Blanco MJ; Gines JM; Rabasco AM; Pérez-Martínez JI; Mor M; Giordano F
    J Pharm Sci; 1997 Jan; 86(1):72-5. PubMed ID: 9002462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational and molecular modeling studies of beta-cyclodextrin-heptagastrin and the third extracellular loop of the cholecystokinin 2 receptor.
    Giragossian C; Schaschke N; Moroder L; Mierke DF
    Biochemistry; 2004 Mar; 43(10):2724-31. PubMed ID: 15005607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-included cyclomaltoheptaose derivative studied by NMR spectroscopy and molecular modelling.
    Berthault P; Duchesne D; Desvaux H; Gilquin B
    Carbohydr Res; 1995 Oct; 276(2):267-87. PubMed ID: 8542602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-cyclodextrin inclusion complexes: effect of the host substitution on molecular recognition].
    Barczáné BA; Barcza L
    Acta Pharm Hung; 2000; 70(3-6):82-8. PubMed ID: 11379035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resonance Rayleigh scattering technology as a new method for the determination of the inclusion constant of beta-cyclodextrin.
    Li N; Luo H; Liu S; Chen G
    Spectrochim Acta A Mol Biomol Spectrosc; 2002 Feb; 58(3):501-7. PubMed ID: 11905535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular structures of the inclusion complexes beta-cyclodextrin-1,2-bis(4-aminophenyl)ethane and beta-cyclodextrin-4,4'-diaminobiphenyl; packing of dimeric beta-cyclodextrin inclusion complexes.
    Giastas P; Yannakopoulou K; Mavridis IM
    Acta Crystallogr B; 2003 Apr; 59(Pt 2):287-99. PubMed ID: 12657820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of aqueous and solid inclusion complexes of diuron and isoproturon with beta-cyclodextrin.
    Dupuy N; Marquis S; Vanhove G; Bria M; Kister J; Vrielynck L
    Appl Spectrosc; 2004 Jun; 58(6):711-8. PubMed ID: 15198824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.